Department of Surgery

Medicine & Life Sciences

1. Colorectal Neoplasms 100%
2. Radiosurgery 88%
3. Stomach Neoplasms 48%
4. Neoplasms 46%
5. Neoplasm Metastasis 40%
6. Survival 37%
7. Arteriovenous Malformations 33%
8. Colonic Neoplasms 27%
9. Taiwan 25%
10. Recurrence 23%
11. Carcinoembryonic Antigen 18%
12. Lymph Nodes 18%
13. Stomach 18%
14. Rectal Neoplasms 17%
15. Gastrectomy 17%
16. Microsatellite Instability 16%
17. Veterans Hospitals 15%
18. Non-Small Cell Lung Carcinoma 14%
19. Adenocarcinoma 14%
20. Cohort Studies 14%
21. Mutation 14%
22. Central Nervous System Vascular Malformations 14%
23. Multicenter Studies 13%
24. Drug Therapy 13%
25. Brain 12%
26. Therapeutics 12%
27. Disease-Free Survival 12%
28. Carcinoma 11%
29. Leucovorin 11%
30. Meningioma 10%
31. Oxaliplatin 10%
32. Adenocarcinoma of Lung 10%
33. Fluorouracil 10%
34. General Hospitals 10%
35. Hemorrhage 9%
36. Radiation 8%
37. Tumor Burden 8%
38. Neoplastic Stem Cells 8%
39. Radiotherapy 7%
40. Microsatellite Repeats 7%
41. Laparoscopy 7%
42. Liver 7%
43. Retrospective Studies 7%
44. Free Tissue Flaps 7%
45. Carcinogenesis 7%
46. Genes 7%
47. Metastasectomy 6%
48. Intracranial Arteriovenous Malformations 6%
49. Cavernous Sinus 6%
50. Acoustic Neuroma 6%
51. Mortality 6%
52. Breast Neoplasms 6%
53. Robotics 6%
54. Lung Neoplasms 6%
55. Chemoradiotherapy 6%
56. Digital Subtraction Angiography 6%
57. MicroRNAs 6%
58. Cell-Free Nucleic Acids 5%
59. Colon 5%
60. Growth 5%
61. Colorectal Surgery 5%
62. Proteins 5%
63. Serum 5%
64. Squamous Cell Carcinoma 5%
65. Progression-Free Survival 5%